Formation Bio

The AI engine Fit Assessment

Beta

Formation Bio effectively leverages machine learning and innovative technologies to expand therapeutic options and repurpose existing drugs, enhancing the drug development process.

Blurb

Formation Bio is a drug development company that strives to provide treatments to patients faster by reimagining clinical trials.

HQ Location

New York (United States)

Founded

2013

Employees

51 - 200

Total funding raised

$528.00M

Funding Status

Series D, $372.00M, June 26, 2024
Subspaces
  • Drug Repurposing

Formation Bio is a tech-driven pharmaceutical company differentiated by radically more efficient drug development. Formation Bio has built a technology platform that optimizes critical aspects of clinical drug development, enabling more efficient trial design, faster trial completion, and higher quality trial data. The company acquires clinical-stage drugs from pharmaceutical and biotech companies with the goal to develop them faster in order to accelerate access to new treatments for patients, and to unlock greater value per program.